Nectar Lifesciences Buyback Record Date 24 December 2025.
Nectar Lifesciences is an integrated pharmaceutical company that has historically focused on manufacturing active pharmaceutical ingredients, intermediates and finished dosage formulations, with a strong specialization in anti‑infective cephalosporin antibiotics. The company operates large API and formulations facilities in Punjab and Himachal Pradesh that comply with major global regulatory standards, enabling supplies to regulated and semi‑regulated markets worldwide.
The company’s product basket has included cephalosporins such as cefixime, cefuroxime and ceftriaxone, alongside other therapeutic categories including antibiotics, anti‑inflammatory and cardiovascular drugs, supplemented by a presence in phytochemicals and menthol‑based products. In 2025, the company entered into agreements to divest its core API, formulations and menthol businesses to Ceph Lifesciences for around INR 1,290 crore, aiming to deleverage its balance sheet and redeploy capital into new growth initiatives while unlocking value for shareholders.
Nectar Lifesciences Buyback Record Date, Other Details
| Nectar Lifesciences Buyback Dates | Coming soon |
| Nectar Lifesciences Buyback Price | INR 27 per share |
| Market Price on Buyback Approval | INR 17.92 per share |
| Buyback Premium on Market Price | 50.67% |
| Buyback Offer Size (Shares) | 3,00,00,000 shares |
| Buyback Offer Size (Amount) | INR 81 crore |
| Offer Type | Tender |
| Promoter Participation | Yes |
| Face Value | INR 1 per share |
| Listing At | BSE, NSE |
Nectar Lifesciences Buyback Dates (Timeline)
| Board Meeting Intimation for Buyback Proposal | 27 November 2025 |
| Buyback Approval Date | 3 December 2025 |
| Public Announcement of Buyback | Coming soon |
| Nectar Lifesciences Buyback Record Date | 24 December 2025 |
| Buyback Opening Date | Coming soon |
| Buyback Closing Date | Coming soon |
| Cut-off Date to receive completed tender forms by Registrar | Coming soon |
| Verification Date by the Registrar | Coming soon |
| Return of unaccepted shares by Registrar | Coming soon |
| Extinguishment of accepted shares | Coming soon |
NecLife Buyback 2025 Documents
Letter of Offer
Public Announcement
Board Approval
Upcoming Share Buyback
Nectar Lifesciences Buyback Entitlement Ratio
| Shareholder Category | Entitlement Ratio | Entitlement Ratio (in %) |
| Small Shareholders (less than INR 2 Lakh on record date) | – | 15.28* |
| General category (for all other Eligible Shareholders) | – | – |
A small shareholder is defined as a shareholder who holds shares worth less than INR 2,00,000 as of the record date.
Nectar Lifesciences Financial Performance
| FY 2023 | FY 2024 | FY 2025 | |
| Total Income | 1,520 | 1,682 | 1,664 |
| Total Expenses | 1,467 | 1,530 | 1,694 |
| Net Income | (24.0) | 5.0 | (114.0) |
Calculation of Investment in Buyback
| Maximum market value of a shareholder as on the record date | INR 2,00,000 |
| Buyback price per share | INR 27 |
| Maximum shares for small shareholders (2,00,000/27) | 7,408 shares * |
| The closing price of the stock as of 3 December 2025 | INR 17.92** |
| Maximum amount invested in buyback (INR 17.92 x 7,408 shares) | INR 1,32,751.36 |
** For simplicity, we have considered the price on the buyback approval date
Nectar Lifesciences Buyback Acceptance Ratio
| Shares Tendered | Buyback Entitlement | Acceptance ratio | Buyback Profit | Profit in % |
| 7,408 | 1,132 | 1,132 (100%) | 10,278.56 | 7.74 |
| 7,408 | 1,132 | 2,264 (200%) | 20,557.12 | 15.49 |
| 7,408 | 1,132 | 3,396 (300%) | 30,835.68 | 23.23 |
Registrar of Nectar Lifesciences Buyback 2025
Coming soon
Manager of Nectar Lifesciences Buyback 2025
Coming soon
The Process to Participate in Nectar Lifesciences Buyback
All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stockbroker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.
The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.
The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.
Frequently Asked Questions
What are Nectar Lifesciences’ buyback dates?
Nectar Lifesciences buyback opens on 2025 and closes on 2025.
Which type of buyback is the Nectar Lifesciences buyback offer?
Nectar Lifesciences’ buyback is a tender offer.
What is the Nectar Lifesciences buyback price?
Nectar Lifesciences’ buyback price is INR 27 per share.
What is the Nectar Lifesciences buyback record date?
Nectar Lifesciences’ buyback record date is 24 December 2025.
How to participate in Nectar Lifesciences’ share buyback?
Nectar Lifesciences’ share buyback will be conducted through the tender process, and investors who hold the shares on the record date can place orders through their broker.